Replimune Group, Inc. Common Stock (REPL) Stock
NASDAQ · REPL
12.46
Fundamentals
Market cap
$1.16B
Price / Earnings ratio
-4.0x
Price / Sales ratio
N/A
Price / Book ratio
11.2x
Return on assets
-82.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Business Wire
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky
NeutralREPLSeptember 11, 2026
Business WireNeutral
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky
REPL

Business Wire
Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.
NeutralREPLSeptember 2, 2026
Business WireNeutral
Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.
REPL

Stocktwits
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
NeutralREPLAugust 27, 2026
StocktwitsNeutral
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
REPL

Business Wire
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - REPL
NeutralREPLAugust 14, 2026
Business WireNeutral
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - REPL
REPL
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesSell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy4
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
2026
0000
Debt & Balance Sheet
Total assets
Total liabilities
2025
2026
662M437M218M0
Revenue to Profit
2026$0.0
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-313.9M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Business Wire
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky
NeutralREPLSeptember 11, 2026
Business WireNeutral
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky
REPL

Business Wire
Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.
NeutralREPLSeptember 2, 2026
Business WireNeutral
Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.
REPL

Stocktwits
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
NeutralREPLAugust 27, 2026
StocktwitsNeutral
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
REPL

Business Wire
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - REPL
NeutralREPLAugust 14, 2026
Business WireNeutral
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - REPL
REPL

Business Wire
REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
NeutralREPLAugust 13, 2026
Business WireNeutral
REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
REPL

Stocktwits
Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?
NeutralREPLAugust 11, 2026
StocktwitsNeutral
Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?
REPL

Business Wire
REPL INVESTOR ALERT: Securities Class Action Filed Against Replimune Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
NeutralREPLAugust 11, 2026
Business WireNeutral
REPL INVESTOR ALERT: Securities Class Action Filed Against Replimune Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
REPL

Stocktwits
REPL Stock Hits Near 18-Month High On Pricing Of $150M Offering – But, Retail Sees Share Price ‘Unwinding Over Time’
NeutralREPLAugust 10, 2026
StocktwitsNeutral
REPL Stock Hits Near 18-Month High On Pricing Of $150M Offering – But, Retail Sees Share Price ‘Unwinding Over Time’
REPL

Zacks Investment Research
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
NeutralREPLAugust 10, 2026
Zacks Investment ResearchNeutral
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
REPL

Business Wire
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REPL
NeutralREPLAugust 10, 2026
Business WireNeutral
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REPL
REPL
About Replimune Group, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees465
CEODr. Sushil Patel Ph.D.
IPO DateJul 20, 2018
HeadquartersWoburn, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Sushil Patel Ph.D. | CEO & Director | 1971 |
| Ms. Emily Luisa Hill | Chief Financial Officer | 1980 |
| Dr. Konstantinos Xynos M.B.A., M.D., Ph.D. | Chief Medical Officer | 1966 |
| Mr. Philip Astley-Sparke F.S.A. | Executive Chairman | 1971 |
| Mr. Andrew Schwendenman | Chief Accounting Officer & Treasurer | 1976 |
| Mr. Shawn Glidden J.D. | Senior VP & General Counsel | — |
| Mr. Camilo Garcia M.A., M.B.A. | Chief Human Resource Officer | — |
| Mr. Paul Bullock | Chief Manufacturing Officer & Framingham Site Head | — |
| Ms. Nina Aragam | Senior Vice President of Portfolio Strategy & Program Management | — |
| Ms. Carolyn Trott | Senior Vice President of Quality Assurance | — |
Fundamentals
Valuation
Market cap$1.16B
Price-to-sales ratioN/A
Price-to-book value11.24
Price-earnings ratio-4.00
Return on Equity-129.00%
Return on SalesN/A
Return on Assets-82.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-3.15
Income Statement
Average volume2,037,638
EBITDA$-299.10M
1 year high (52w)$16.33
1 year low (52w)$1.50
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesSell12 Indicators
What the experts say
4 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$19.00
Est return
53.85%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0.4 | -0.1 | -7.5 | -3.2 | ||||||||
| 2022 | -32.3 | -17.2 | +6.3 | -8.2 | -13.6 | +19.9 | +4.9 | +1.5 | -9.9 | +7.2 | +7.4 | +36.1 |
| 2023 | +5.7 | -23.4 | -20.8 | -4.8 | +8.5 | +25.6 | -3.9 | -0.6 | -13.2 | -7.7 | -21.8 | -28.0 |
| 2024 | -10.5 | +9.2 | -8.9 | -17.9 | -18.7 | +65.4 | +6.8 | -0.5 | +6.6 | -1.2 | +18.3 | -10.6 |
| 2025 | +11.3 | -7.5 | -19.6 | +16.4 | -6.8 | -2.9 | -23.2 | -28.9 | -29.0 | +131.1 | +7.4 | +0.1 |
| 2026 | -21.0 | +9.6 | +6.8 | -66.2 | +247.6 | +23.0 | -0.2 | +28.5 | -21.1 |



